Are we close to finding a cure for HIV thanks to a new cancer drug?

Published February 18 2022 inSexual Health
stopwatch2 minutes read

In 2020, there were an estimated 29,090 people living with HIV in Australia. An estimated 91% of those people were diagnosed by the end of 2020. Research shows that 91% of people diagnosed were receiving HIV treatment, and 97% of those on treatment, had an undetectable viral load.

In 2020, 58% of HIV notifications were due to sexual contact between men. 24% of the cases were attributed to heterosexual sex, 10% to a combination of sexual contact between men and injecting drug use. 3% was due to drug use alone with the remaining 5% classed as other or unspecified.

This snippet from an infographic by the Australian Federation of AIDS organisations (AFAO) notes that Covid-19 has caused a dramatic reduction in HIV notifications and highlights the need to increase testing rates to pre-pandemic levels.

What are the recent research advances for an HIV cure?

Professor Sharon Lewin, director of the Doherty Institute in Melbourne has discovered a medicine used to treat cancer can also draw HIV out of hibernation, exposing the virus to the immune system and make it more vulnerable to attack.

HIV can “hide” in cells, even in patients on antiretroviral therapy and with undetectable amounts of the virus in their blood. This is one of the major barriers to seeking a cure for the disease.

In cancer patients, killer T-cells become dysfunctional which leads to them expressing exhaustion proteins on their surface called PD-1. Previous research by Lewin found      PD-1 is the same exhaustion marker which allows HIV to hide in cells

An immunotherapy drug administered intravenously blocks these exhaustion markers in cancer patients. This allows the killer T-cells to regain function and fight the cancer.

Professor Lewin and her team tested the cancer drug against the virus by giving it to 32 patients living with HIV who also have cancer. They uncovered that the drug did have anti-PD-1 properties, and this discovery was published in January 2022.

There is now proof that the drug can reverse latency in HIV patients but whether anti-PD-1 can also boost the immune system enough to then attack and destroy HIV will now form part of future research.

Confidential testing for STIs or HIV

If you have any questions about HIV testing and STI testing or your general sexual health then please speak with one of our highly trained advisors, either by phone or through our live online webchat using the number or button at the top of this page.

Better2Know, the world´s leading private sexual health testing provider, can make you an appointment at a sexual health clinic near you and arrange confidential consultations and appointments. We provide a wide range of tests and comprehensive screens to meet your needs. Your personal advisor is here to address your sexual health concerns 24 hours a day, 7 days a week.

ABOUT THE AUTHOR

Mike has been delivering world class Sexually Transmitted Infections testing services to Better2Know patients around the world for over ten years. He has written extensively on the subject, including numerous blogs for Better2Know which are designed to demystify the complex intricacies of sexual health testing. Mike wants to help his readers understand the risks they take in their daily sexual lives and provide the information they need when choosing an STI or STD test in a clear, concise and understandable way. Mike is particularly interested in writing about viral STIs like HIV and Hepatitis, as these infections can have a devastating impact on people’s lives if they are not diagnosed quickly. Only through being well informed can you best care for your health, and Mike is passionate about sharing his knowledge and experience to help you and all his readers lead a happier, healthier life.